Martinsried, Germany – KINAXO Biotechnologies GmbH announced today that it has entered into a collaboration with AstraZeneca. Under the terms of the agreement, KINAXO will
Sartorius Appoints International Life Sciences Leader to its Top Management
03 January 2011
Goettingen, Germany – Effective January 1, 2011, the former Millipore executive, Dominique Baly, has assumed cross-divisional management of marketing,
Biogen Idec and Neurimmune Announce Agreement on Three Neurodegenerative Disease Programs
21 December 2010
Biogen Idec (NASDAQ: BIIB) and Neurimmune Holding AG today announced that Biogen Idec has acquired a subsidiary of Neurimmune, which includes the world-wide rights to
Biotage Announces an Easy, Cost-Effective Approach to the Analysis of Ethyl Glucuronide (EtG) in Urine
16 December 2010
Uppsala, Sweden – Biotage® (STO: BIOT), a leading supplier of tools and technology for analytical and medicinal chemistry, introduced a new sample preparation application
HELM AG Acquires Shares in Amarin Technologies S.A.
15 December 2010
Effective September 28th, 2010, Hamburg based HELM AG has purchased a 30% shareholding in Amarin Technologies S.A. a privately owned pharmaceutical development
Gene Logic announces appointment of Norrie Russell as President
06 September 2010
Gene Logic, an Ocimum Biosolutions company, a leading provider of genomic solutions, is pleased to
Mucosis Receives Financial Support from the Dutch Government
31 May 2010
Dutch vaccine development company Mucosis B.V. announced today that it has received an innovation
Ubichem Approved for cGMP Radiolabelled API Production
31 May 2010
Ubichem, a leading provider of chemistry services to the drug development sector, through its Hungarian
Preclinical data shows Restanza to be effective against gonorrhea
28 May 2010
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization
VaxGen to Acquire diaDexus
28 May 2010
VaxGen, Inc. , a biopharmaceutical company, and diaDexus, Inc., a privately held diagnostics company
Life Technologies acquires major stake in Geneart
28 May 2010
Life Technologies Corporation, a provider of innovative life science solutions, announced today that it has
BioFinance
Global Market of Biological Therapies for Cancer to Be Worth $54 Billion In 2014
Posted on 22 April 2010
April 22, 2010 – According to a new technical market research report, Biological Therapies for Cancer:
Biotech Startups News
Neurimmune Therapeutics AG Awarded the 2010 ZKB TECHNOPARK® Pioneer Award
Posted on 13 April 2010
The ZKB TECHNOPARK® Pioneer Award, which has been sponsored by the Zürcher Kantonalbank since
Clinical Trials
Key to Successful Treatment of Transgender Patients May Involve Delay of Puberty
Posted on 24 April 2010
Complications from transgender procedures may be significantly minimized when treatment of a patient with severe gender identity
Industry hires and promotions
Gene Logic announces appointment of Norrie Russell as President
Posted on 06 September 2010
Gene Logic, an Ocimum Biosolutions company, a leading provider of genomic solutions, is pleased to
IPO News
Acorda Therapeutics Announces Pricing of Initial Public Offering
Posted on 10 February 2006
Acorda Therapeutics (Nasdaq: ACOR) announced today the initial public offering of 5,500,000 shares of common stock at a price of $6.00 per share. All of the shares are being offered by Acorda Therapeutics. Acorda’s common stock will begin trading today on The NASDAQ National Market under the symbol “ACOR.”
Merger & Acquisition
Biogen Idec and Neurimmune Announce Agreement on Three Neurodegenerative Disease Programs
Posted on 21 December 2010
Biogen Idec (NASDAQ: BIIB) and Neurimmune Holding AG today announced that Biogen Idec has acquired a subsidiary of Neurimmune, which includes the world-wide rights to
New Produtcs & Services
Beautiful Minds: Finding Your Lifelong Potential
Posted on 27 May 2010
Martek Biosciences, in partnership with the National Center for Creative Aging today introduced “Beautiful
Patent News
Rosetta Genomics Strengthens MicroRNA Intellectual Property Position with Receipt of Additional Patent
Posted on 05 November 2009
Nov. 5 – Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO)
Regulatory Affairs
Consumers Advised Not to Use Arrow Brand Medicated Oil & – Embrocation
Posted on 27 May 2010
The U.S. Food and Drug Administration today warned consumers not to purchase or use a product called
| Amgen Inc. | 69.15 | ||
| Affymetrix, Inc. | 4.79 | ||
| Biocryst Pharmace | 3.30 | ||
| Biogen Idec Inc. | 131.58 | ||
| Cel-sci Corporati | 0.39 | ||
| Covance Inc. Comm | 44.60 | ||
| Cra | 0.00 | ||
| Dna | 0.00 | ||
| Enzon Pharmaceuti | 6.02 | ||
| Genz | 0.00 | ||
| Gilead Sciences, | 49.94 | ||
| Glaxosmithkline P | 44.18 | ||
| Human Genome Scie | 13.99 | ||
| Illumina, Inc. | 42.85 | ||
| Incyte Corporatio | 21.75 | ||
| Integra Lifescien | 32.96 | ||
| Johnson & Johnson | 63.35 | ||
| Life Technologies | 41.01 | ||
| Merck & Company, | 37.821 | ||
| Myriad Genetics, | 24.54 | ||
| Novartis Ag Commo | 51.72 | ||
| Pfizer, Inc. Comm | 22.57 | ||
| Pgla | 0.00 | ||
| Qiagen N.v. | 16.46 | ||
| Abbott Laboratori | 61.57 | ||
| Mfc Industrial Lt | 6.80 |
Warning: require_once(/home/scholar/public_html/carp/carp.php) [function.require-once]: failed to open stream: No such file or directory in /home/scholar/public_html/biowire/wp-content/themes/pharma/sidebar_home.php on line 14
Fatal error: require_once() [function.require]: Failed opening required '/home/scholar/public_html/carp/carp.php' (include_path='.:/usr/lib/php:/usr/local/lib/php') in /home/scholar/public_html/biowire/wp-content/themes/pharma/sidebar_home.php on line 14